SCHEMBL23045656

SCHEMBL23045656

CCOC(=O)c1cc2cc(N)ccc2n1CCCOC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NOD2 Q9HC29 1/20 0.44
NOD1 Q9Y239 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PTGER4 P35408 2/20 0.43
TSHR P16473 3/20 0.42
GAA P10253 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 3/20 0.42
F10 P00742 2/20 0.42
GLA P06280 2/20 0.42
HPGD P15428 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29463264 1.00 KDM4E (0.47) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL23045682 0.93 KDM4E (0.49) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL29463272 0.93 KDM4E (0.49) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL31383507 0.89 KDM4E (0.50) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL23045589 0.89 KDM4E (0.50) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL23045603 0.87 KDM4E (0.52) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL31383524 0.87 KDM4E (0.52) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL23045587 0.85 NOD2 (0.47) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL29463233 0.85 NOD2 (0.47) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL29463267 0.84 KDM4E (0.65) KDM4ECRHBPCRHR2SMN1; SMN2NOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12465588-B2 Indole carboxamide derivative and pharmaceutical composition containing same KUKJE PHARMA CO., LTD. (KR) 2025-11-11 US disclosed
US-20230000821-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME KUKJE PHARMA CO., LTD. (KR) 2023-01-05 US disclosed
EP-4023638-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Kukje Pharma Co., Ltd. (KR) 2022-07-06 EP disclosed
CN-114302874-A Indole carboxamide derivatives and pharmaceutical compositions comprising same 国际药品株式会社 2022-04-08 CN disclosed
WO-2021040393-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 국제약품 주식회사 2021-03-04 WO disclosed
WO-2021040393-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 국제약품 주식회사 2021-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12465588-B2 Indole carboxamide derivative and pharmaceutical composition containing same PTGES, PTGES2, PTGS1 KDM4E 2460/4885CRHBP 1420/4885CRHR2 878/4885
US-20230000821-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME PTGES, PTGES2, PTGS1 KDM4E 2460/4885CRHBP 1420/4885CRHR2 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.